Assignee
ALEXANDER SHULGIN RES INSTITUTE INC
US·5 granted patents·4 pending applications·2 citations·filing 2022–2025
Top patents by PatentIndex Score
9 records- 0187US12221428B2Use of deuterated empathogens as therapeutic agentsALEXANDER SHULGIN RES INSTITUTE INC·Filed 2024·Granted Feb 11, 2025·2 cites·20 claims
- 0274US12239632B2Asymmetric allyl tryptaminesALEXANDER SHULGIN RES INSTITUTE INC·Filed 2024·Granted Mar 4, 2025·0 cites·20 claims
- 0370US12043605B2Deuterated empathogensALEXANDER SHULGIN RES INSTITUTE INC·Filed 2022·Granted Jul 23, 2024·0 cites·14 claims
- 0470US2025129037A1Fluorinated empathogensALEXANDER SHULGIN RES INSTITUTE INC·Filed 2024·Application pending·0 cites
- 0567US12180176B2Fluorinated empathogensALEXANDER SHULGIN RES INSTITUTE INC·Filed 2022·Granted Dec 31, 2024·0 cites·15 claims
- 0665US12465578B2Substituted alpha-ethyl phenylalkylaminesALEXANDER SHULGIN RES INSTITUTE INC·Filed 2022·Granted Nov 11, 2025·0 cites·20 claims
- 0762US2025179042A1Use of deuterated empathogens as therapeutic agentsALEXANDER SHULGIN RES INSTITUTE INC·Filed 2025·Application pending·0 cites
- 0859US2025388529A1N-Substituted Phenylalkylamines and Their Use as Therapeutic AgentsALEXANDER SHULGIN RES INSTITUTE INC·Filed 2023·Application pending·0 cites
- 0956US2025195471A1Asymmetric allyl tryptaminesALEXANDER SHULGIN RES INSTITUTE INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ALEXANDER SHULGIN RES INSTITUTE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →